Price (delayed)
$297.32
Market cap
$11.51B
P/E Ratio
270.29
Dividend/share
N/A
EPS
$1.1
Enterprise value
$11.36B
Penumbra, Inc., headquartered in Alameda, California, is a global healthcare company focused on innovative therapies. Penumbra designs, develops, manufactures and markets novel products and has a broad portfolio that addresses
There are no recent dividends present for PEN.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from and Sharadar.